US2012003297A1PendingUtilityA1
Compositions and methods for treating lymphoma
Est. expiryApr 1, 2019(expired)· nominal 20-yr term from priority
Inventors:Andreas H. SarrisFernando CabanillasPatricia M. LoganClive BurgeJames H. GoldieMurray Webb
A61P 35/00A61K 9/127A61K 31/704A61K 9/1278A61K 31/475A61P 35/04
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
Claims
exact text as granted — not AI-modified1 - 70 . (canceled)
71 . A method for treating cancer in a mammal, said method comprising administering to said mammal a composition comprising liposome-encapsulated vincristine at a dosage of about 1.5 mg/m 2 to about 2.4 mg/m 2 , wherein the liposome comprises sphingomyelin and cholesterol.Join the waitlist — get patent alerts
Track US2012003297A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.